|
gptkbp:instance_of
|
gptkb:hospital
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:BD_Diagnostics
|
|
gptkbp:application
|
COVID-19 testing
influenza testing
strep testing
|
|
gptkbp:availability
|
widely available
|
|
gptkbp:clinical_trial
|
15 minutes
conducted
|
|
gptkbp:competitors
|
Abbott Binax NOW
Quidel Sofia
Roche Rapid Antigen Test
|
|
gptkbp:demographics
|
varied
|
|
gptkbp:distribution
|
worldwide
|
|
gptkbp:feedback
|
generally positive
|
|
gptkbp:format
|
positive/negative
|
|
gptkbp:healthcare
|
gptkb:battle
|
|
gptkbp:historical_context
|
visual readout
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
BD Veritor
|
|
gptkbp:is_tested_for
|
gptkb:software
high
controls
swabs
peer-reviewed studies
lateral flow assay
false negatives possible
false positives possible
test device
|
|
gptkbp:is_used_for
|
rapid detection of infectious diseases
|
|
gptkbp:launch_date
|
gptkb:2014
|
|
gptkbp:manufacturer
|
gptkb:Becton,_Dickinson_and_Company
|
|
gptkbp:market
|
global
|
|
gptkbp:notable_traits
|
high
|
|
gptkbp:outcome
|
15-30 minutes
|
|
gptkbp:part_of
|
gptkb:BD_Diagnostics
|
|
gptkbp:partnerships
|
various healthcare organizations
|
|
gptkbp:performance
|
monitored regularly
|
|
gptkbp:platform
|
point-of-care testing
|
|
gptkbp:price
|
varies by provider
|
|
gptkbp:primary_user
|
gptkb:hospital
|
|
gptkbp:provides_information_on
|
followed by users
|
|
gptkbp:recorded_by
|
nasal swab
nasopharyngeal swab
|
|
gptkbp:regulatory_compliance
|
CLIA waived
|
|
gptkbp:research
|
ongoing
|
|
gptkbp:sensor
|
high
|
|
gptkbp:shelf_life
|
12 months
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:target_audience
|
hospitals
clinics
pharmacies
urgent care centers
|
|
gptkbp:training
|
available online
minimal
|
|
gptkbp:type
|
antigen test
|